SCHEMBL7677660

SCHEMBL7677660

COc1cc(-c2nc(NC(=O)c3cc4ccccc4n3CC(=O)[O-])sc2CCC2CCCCC2)c(OC)cc1C.[Na+]

nearest known ligand 0.37

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IMPDH2 known ✓ P12268 1/20 0.34
F10 known ✓ P00742 2/20 0.32
TRPV4 Q9HBA0 7/20 0.37
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
CCKAR P32238 1/20 0.35
SAE1 Q9UBE0 1/20 0.34
UBA2 Q9UBT2 1/20 0.34
PLTP P55058 2/20 0.34
ECE1 P42892 1/20 0.34
GAA P10253 1/20 0.33
CNR2 P34972 1/20 0.33
POLB P06746 1/20 0.33
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682217 0.93 TRPV4 (0.38) TRPV4KMT2AMEN1CCKARSAE1
SCHEMBL7684903 0.93 KMT2A (0.42) TRPV4KMT2AMEN1CCKARSAE1
SCHEMBL7688497 0.93 MEN1 (0.39) TRPV4KMT2AMEN1CCKARIMPDH2
SCHEMBL7684406 0.93 MAPT (0.34) TRPV4KMT2AMEN1PLTPECE1
SCHEMBL7682301 0.88 TRPV4 (0.40) TRPV4KMT2AMEN1CCKARSAE1
SCHEMBL7679717 0.85 MEN1 (0.40) TRPV4KMT2AMEN1CCKARPLTP
SCHEMBL7688740 0.85 MEN1 (0.46) TRPV4KMT2AMEN1CCKARPLTP
SCHEMBL7686591 0.85 TRPV4 (0.36) TRPV4KMT2AMEN1CCKARPLTP
SCHEMBL7679779 0.85 TRPV4 (0.37) TRPV4KMT2AMEN1CCKARSAE1
SCHEMBL6702441 0.85 MAPT (0.39) TRPV4KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380230-B1 FOR THERAPY OF DYSKINESIA, OBESITY, IRRITABLE BOWEL SYNDROME, DISEASES WHOSE TREATMENT REQUIRES STIMULATION OF THE CHOLECYSTOKININ CCK-A RECEPTORS SANOFI-SYNTHELABO (FR) 2002-04-30 US disclosed